venture capital fund - Merieux Equity Partners

Venture Capital Fund

We stay true to our mission, you develop your vision

venture capital FUND
We share,
you dare

You are developing best in class product(s) or platform in healthcare and nutrition with a top quality team and entrepreneurial drive with a clearly defined pathway to value inflection points.

You are ready to achieve as much as you dare to strive.

We are a Venture Capital investor in the healthcare, life sciences and nutrition sectors.

We can help you structure and expand your entrepreneurial project, operating as a genuine business partner. Our team is ready to share decades of experience in product development, manufacturing, regulatory affairs, intellectual property, as well as human resources management, thanks to our business and industrial network.

We believe the 21st century will be biology-driven, where the promise of precision medicine and a biology-led industrial revolution hinge on the ability to reduce the complex interconnections of large, multi-omic data sets into useful biological information, services and products. We believe that this will ultimately lead to a sizeable market opportunity, better and cost-effective healthcare, while also addressing large social challenges such as a sustainable food supply chain. 

  • 17
    Supported Companies
  • 8
    Number of Exits
  • 19
    Product Approvals

Our Investment Vehicles to date

OMX Europe Venture Fund (2020)

  • €117M
    Fund Size
  • 15
    Companies to be invested
  • 8
    Number of active portfolio companies
  • €5M to €12M
    Investment Range (including co-investment capacity)
  • Investment Phase



Omics [ō-miks]: Refers to a field of study in biology ending in -omics (such as genomics, proteomics, metabolomics, microbiomics, etc.) in a cell, organ, or organism.

OMX Europe Venture Fund is a life science venture fund managed by Mérieux Equity Partners with the co-sponsorship of Korys and Mérieux Développement. This VC Fund, through its direct link with Korys, brings together decades of expertise of investing and supporting entrepreneurship in the life science and nutrition sectors. The Fund’s strategy is to invest in highly innovative companies and best-in-class platforms at pre-commercial or commercial stage in Western Europe and North America. 

Mérieux Participations 2 (2014)

  • €150M
    Fund Size
  • 6
    Companies invested
  • 5
    Number of active companies within portfolio
  • €4M to €14M
    Investment Range
  • Active Management/Exit Phase

Mérieux Participations 1 (2009)

  • €70M
    Fund Size
  • 10
    Companies invested
  • 1
    Number of active portfolio companies
  • €1M to €13M
    Investment Range
  • Exit Phase

Date: April 2022  /  Source: Mérieux Equity Partners

Disclaimer: This page is dedicated to entrepreneurs. The information on this page should not be construed as an invitation to invest.

Our Industrial Network

Mérieux Equity Partners is an independent management company sponsored by Institut Mérieux – an industrial holding that has contributed to major advances in medecine and public health at a global level over four generations of the Mérieux family. This means we can offer to our portfolio companies priviledged access to an international industrial network, including bioMérieux, Mérieux NutriSciences, ABL and Transgene.

Our Business Partners

Our business partners include Senior/Strategic Advisors as well as Korys and M2Care in Europe. 

MxEP's Senior Advisors

Korys is the family office of the Belgium-based Colruyt family. Today, it has €5 billion of assets under management. Besides holding a significant participation in the Colruyt Group - a leading retail company in Belgium and France - it actively manages participations in privately held companies, private equity funds and quoted financial instruments. Across its activities, Korys’ investment decisions are taken with a long-term perspective and on the basis of strict economic (Profit), social (People) and ecological (Planet) criteria in order to create sustainable value in three major ecosystems: Life Sciences, Energy Transition and Conscious Consumer. To do this, Korys can count on a motivated team of 30 professionals based in Belgium and Luxembourg.

Korys' Life Science Team

M2Care is a Venture studio launched in 2019 and located in France that offers a differentiated model at the crossroads of innovation, investment and technology - dedicated to build and/or accelerate disruptive startups and ventures. M2Care is working with key actors of the innovation sector: start-ups, corporates, VCs and TTOs with the aim of derisking all new and existing businesses. They bring an international experienced ecosystem to manage all business dimensions : 60+ experts & partners, specialized in all stages of development in MedTech / Biotech / Nutrition projects.

Pertinence Invest 2 (“PI2”) is a Seed Fund launched in 2020 by UI Investissement (formerly Sofimac Innovation), in partnership with French leading engineering schools and universities, focusing on industry 4.0, new energies, new materials, digitalization and breakthrough platforms serving the Health & Nutrition sectors. This program federates an entire eco-system including some of the leading industrial companies in France (bioMérieux, Michelin, Seb, etc.) and it supports start-ups that have emerged directly from the research labs of its academic partners or are directly linked to them.

Mérieux Equity Partners is an advisor to UI Investissement for the Fund's investments in the Health and Nutrition sectors. The Fund's strategy is to invest in highly innovative companies and best-in-class platforms at early stage of development with ticket sizes ranging from €0.3M to €3M.